Inogen Reports Inducement Grants

Got story updates? Submit your updates here. ›

Inogen, Inc., a medical device company focused on portable oxygen concentrators, announced that it has granted inducement stock options to new employees pursuant to Nasdaq Listing Rule 5635(c)(4). The options were granted as an inducement material to the new employees' employment with the company.

Why it matters

Inducement grants are a common practice for public companies to attract and retain top talent, especially in competitive industries like biotech. These grants provide new employees with a stake in the company's future performance and align their interests with shareholders.

The details

The stock options were granted to 12 new employees on March 30, 2026. The options have an exercise price equal to the closing price of Inogen's common stock on the grant date and will vest over a four-year period, subject to the employees' continued service with the company.

• The options were granted on March 30, 2026.